Analyst's Key Takeaways From Eli Lilly, Bristol-Myer Squibb's Latest Conference Calls
July 23, 2015 at 16:01 PM EDT
In separate reports published Thursday, Evercore-ISI's Biotechnology analyst Mark Schoenebaum dissected Eli Lilly and Co (NYSE: LLY) and ...